VIEWS: 10 PAGES: 3 POSTED ON: 6/7/2012
Sefton Drug Action Team Summary Report for the PCT Board Quarter end June 30th 2007 Background: This report provides an update for the first quarter of the financial year 2007/8. NTA Quarterly Performance Report Numbers in Treatment New presentations 156 Number in treatment YTD 1230 NTA year end projection 1513 NTA LDP target 1404 The stretch target recently suggested by the NTA of 1,565 is achievable. Past trends suggest that based on the current level of activity of 1,230 that the 1,565 is a more realistic figure than the 1,513 projected number in treatment at 31st March 2008. Retention (in treatment minimum period of 12 weeks) NTA Target Actual Retention 85% 77% Given that Sefton DAT ultimately achieved 87% retention in 2006/7 the current level of retention defined by the NTA is under query. Waiting Times (all modalities – less than 3 weeks max wait) NTA Target Actual First intervention 83% 95% Subsequent intervention 83% 89% Successful Treatment Discharges (all modalities) NTA Target Actual Treatment Discharge 52% 61% Care Planning NTA Target Actual Care Planning 95% 99% Analysis of Drug Misuse – Presenting Substance Drug Type Main Second Third Heroin 888 75% 35 3% 3 0% Cocaine 91 8% 53 4% 31 3% Methadone 50 4% 62 5% 29 2% Cannabis 51 4% 39 3% 23 2% Crack 19 2% 341 29% 16 1% Other main drugs 48 4% 4 0% 3 0% N/A 0 0% 567 48% 1026 87% N.B These are the main drugs used. There are many other drugs listed making up the total percentage figure to 100% in each of main, second and third drug of choice columns. NTA Summary There are no major concerns over the Sefton partnership. Service user involvement is our best regionally (if not nationally) and it is felt the commissioning and management of the drug treatment system is excellent. Developments 1. Data provision: The DAT has invested in new systems within its main service provider to ensure that accurate data recording is evidenced for the DAT. 2. Increased outreach team: In order to ensure those clients that are hard to reach are encouraged into treatment the DAT has supported the expansion of the local outreach team and has assisted in the purchase of an outreach vehicle. 3. Improved access to harm reduction: There has been a 25% increase in the number of pharmacies participating in both supervised consumption of methadone and in the provision of syringe exchange services. 4. Increased range of accommodation/housing options for our clients as per housing strategy. 5. Restructuring criminal justice services to provide a more cost effective service in 2008/9. Healthcare Commission Review Sefton DAT achieved a grade ‘4’ rating which is the highest of the ratings available. Only 27% of the Drug Action Teams achieved this rating. Key success points Robust commissioning mechanisms with formal partnerships/key stakeholders and service users. Compliance with Models of Care in respect of range/quality of treatment services available. Waiting times favourable Service retention favourable Well informed harm reduction strategy Excellent monitoring of service provision. Healthcare Commission recommendations The DAT is keen to increase the number of injecting drug users that utilise needle/syringe exchange services and improve the workforce strategy for Sefton services. These items will be priorities for the latter half of 2007/8. Summary The first quarter performance in respect of activity and outcomes show a healthy position for Sefton DAT. The financial position is similarly healthy and it is anticipated that the DAT will break even at 31st March 2008.
Pages to are hidden for
"Sefton Drug Action Team"Please download to view full document